About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:2662104
Allelic
Composition
Cd59atm1Bpm/Cd59atm1Bpm
Genetic
Background
involves: 129/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd59atm1Bpm mutation (0 available); any Cd59a mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• homozygotes exhibit a significant increase in reticulocyte count relative to wild-type mice
• however, homozygotes are not anemic, and hemoglobin concentration, red cell number, white cell number, and platelet number are within normal range at both ages tested
• at 10 weeks of age, male homozygotes display higher reticulocyte counts than female homozygotes (mean of 5.63% vs 4.23%) and shorter calculated t1/2 (7.9 days vs 10.7 days)
• in vitro, mutant erythrocytes are much more susceptible in a classical pathway assay to lysis by homologous or heterologous serum than heterozygous or wild-type erythrocytes
• mutant erythrocytes bearing human or rat C5b-7 sites are extremely susceptible to lysis when either rat or mouse serum is provided as a source of terminal C components, whereas similarly treated wild-type cells are resistant
• furthermore, mutant erythrocytes are positive in the acidified serum lysis assay (Ham test), whereas wild-type erythrocytes are negative (i.e. they do not lyse)

homeostasis/metabolism
• at 10 weeks of age, homozygotes display spontaneous intravascular hemolysis with a significant rise in mean plasma hemoglobin concentration relative to wild-type mice (12.6 g/L vs 4.8 g/L, respectively), as measured by spectrophotometry at multiple wavelengths
• notably, plasma hemoglobin concentration is significantly higher in male homozygotes than in female homozygotes (14.6 g/L vs 10.6 g/L, respectively), although erythrocytes tested in vitro are equally susceptible to complement lysis
• administration of cobra venom factor (CVF) to male homozygotes causes a further increase in intravascular hemolysis, as shown by a significant rise in plasma hemoglobin concentration at 1 hr after CVF treatment; by contrast, only a modest increase in hemoglobin concentration is observed in CVF-treated female homozygotes
• analysis of plasma hemolytic activities indicate that male homozygotes have significantly higher hemolytic complement activities, providing a putative explanation for the observed sex differences
• at 8 weeks of age, homozygotes exhibit significant hemoglobinuria, as determined by measuring absorbance at 412 nm

renal/urinary system
• at 8 weeks of age, homozygotes exhibit significant hemoglobinuria, as determined by measuring absorbance at 412 nm

growth/size/body
• male, but not female, homozygotes are consistently 10% (2 to 3 g in adults) lighter than their wild-type counterparts
• however, both sexes are fully viable, fertile, and otherwise normal up to 30 weeks of age


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory